BLCM
Bellicum Pharmaceuticals Inc
A Houston-based biopharmaceutical company that engineers cellular immunotherapies, including CAR-T cell therapies, to treat cancers and blood disorders. Its technology includes GoCAR, designed to make engineered immune cells more effective, and CaspaCIDe, a built-in "kill switch" that lets doctors turn off the cells for safety. Founded in 2004 by physician-scientist Kevin Slawin, the company takes its name from the Latin "bellicum," meaning a military trumpet call that signals the start of battle—a fitting call to arms in the fight against cancer.
CUSIP: 079481107HealthcareUS1 holder
Recent Activity
2020Q1
1 sell
-417.4K shares
ARK InvestEXIT
-417.4K shares
Loading more activity...